Pomanda estimates the enterprise value of GUARDIAN PHARMACY LIMITED at £2.3m based on a Turnover of £5.9m and 0.38x industry multiple (adjusted for size and gross margin).
guardian pharmacy limitedEstimated Valuation
£460.4k
Pomanda estimates the enterprise value of GUARDIAN PHARMACY LIMITED at £460.4k based on an EBITDA of £109.1k and a 4.22x industry multiple (adjusted for size and gross margin).
guardian pharmacy limitedEstimated Valuation
£87.2k
Pomanda estimates the enterprise value of GUARDIAN PHARMACY LIMITED at £87.2k based on Net Assets of £44.1k and 1.98x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Guardian Pharmacy LimitedOverview
Guardian Pharmacy Limited is a live company located in peterborough rd, harrow, HA1 2AX with a Companies House number of 06324300. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in July 2007, it's largest shareholder is
mr joe sivadasam
with a 25% stake. Guardian Pharmacy Limited is a established,
mid sized company, Pomanda has estimated its turnover at
£5.9m with
healthy
growth in recent years.
Pomanda's financial health check has awarded Guardian Pharmacy Limited a 2.5 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 7 areas for improvement. Company Health Check FAQs
Health Rating2.5out of 5
2 Strong
3 Regular
7 Weak
Size
annual sales of £5.9m, make it smaller than the average company (£12.6m)
£5.9m - Guardian Pharmacy Limited
£12.6m - Industry AVG
Growth
3 year (CAGR) sales growth of 8%, show it is growing at a similar rate (7.3%)
8% - Guardian Pharmacy Limited
7.3% - Industry AVG
Production
with a gross margin of 30.9%, this company has a comparable cost of product (30.9%)
30.9% - Guardian Pharmacy Limited
30.9% - Industry AVG
Profitability
an operating margin of -0.4% make it less profitable than the average company (2.5%)
-0.4% - Guardian Pharmacy Limited
2.5% - Industry AVG
Employees
with 47 employees, this is below the industry average (62)
47 - Guardian Pharmacy Limited
62 - Industry AVG
Pay Structure
on an average salary of £26.5k, the company has an equivalent pay structure (£26.5k)
£26.5k - Guardian Pharmacy Limited
£26.5k - Industry AVG
Efficiency
resulting in sales per employee of £126k, this is less efficient (£149.9k)
£126k - Guardian Pharmacy Limited
£149.9k - Industry AVG
Debtor Days
it gets paid by customers after 48 days, this is later than average (29 days)
48 days - Guardian Pharmacy Limited
29 days - Industry AVG
Creditor Days
its suppliers are paid after 49 days, this is quicker than average (63 days)
49 days - Guardian Pharmacy Limited
63 days - Industry AVG
Stock Days
it holds stock equivalent to 18 days, this is less than average (32 days)
18 days - Guardian Pharmacy Limited
32 days - Industry AVG
Cash Balance
has cash to cover current liabilities
for 29 weeks, this is more cash available to meet short term requirements (12 weeks)
29 weeks - Guardian Pharmacy Limited
12 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 97.8%, this is a higher level of debt than the average (59.1%)
97.8% - Guardian Pharmacy Limited
59.1% - Industry AVG
GUARDIAN PHARMACY LIMITED financials
EXPORT
Guardian Pharmacy Limited's latest turnover from March 2024 is estimated at £5.9 million and the company has net assets of £44.1 thousand. According to their latest financial statements, Guardian Pharmacy Limited has 47 employees and maintains cash reserves of £447.9 thousand as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Mar 2020
Mar 2019
Mar 2018
Mar 2017
Mar 2016
Mar 2015
Mar 2014
Mar 2013
Mar 2012
Mar 2011
Mar 2010
Turnover
5,923,593
5,575,998
5,888,676
4,739,034
4,860,419
4,654,223
4,858,210
4,698,080
4,089,003
3,573,205
3,363,115
2,699,846
2,519,045
1,784,847
1,551,711
Other Income Or Grants
Cost Of Sales
4,091,679
3,750,919
3,935,206
3,259,352
3,379,241
3,202,692
3,288,173
3,184,179
2,827,658
2,493,807
2,328,108
1,878,566
1,780,860
1,255,384
1,079,445
Gross Profit
1,831,914
1,825,079
1,953,470
1,479,682
1,481,178
1,451,531
1,570,037
1,513,901
1,261,345
1,079,399
1,035,007
821,281
738,185
529,463
472,266
Admin Expenses
1,858,781
1,689,317
1,996,859
1,190,799
1,436,192
1,533,776
1,579,223
1,446,086
1,139,394
1,134,256
889,680
667,557
646,157
399,701
427,592
Operating Profit
-26,867
135,762
-43,389
288,883
44,986
-82,245
-9,186
67,815
121,951
-54,857
145,327
153,724
92,028
129,762
44,674
Interest Payable
109,522
108,340
77,439
75,618
80,999
94,481
81,491
75,044
57,373
26,560
24,375
21,938
9,750
Interest Receivable
28,416
30,560
6,243
576
340
2,614
939
197
363
646
738
265
134
176
74
Pre-Tax Profit
-107,972
57,981
-114,586
213,841
-35,673
-174,112
-89,738
-7,032
64,941
-80,771
121,690
132,051
82,412
129,939
44,749
Tax
-11,016
-40,630
-12,988
-27,989
-31,692
-21,427
-36,383
-12,530
Profit After Tax
-107,972
46,965
-114,586
173,211
-35,673
-174,112
-89,738
-7,032
51,953
-80,771
93,701
100,359
60,985
93,556
32,219
Dividends Paid
Retained Profit
-107,972
46,965
-114,586
173,211
-35,673
-174,112
-89,738
-7,032
51,953
-80,771
93,701
100,359
60,985
93,556
32,219
Employee Costs
1,247,564
1,321,979
1,530,449
1,106,483
1,127,673
1,149,737
1,343,647
1,392,881
1,185,050
537,251
499,605
388,142
318,961
236,662
201,281
Number Of Employees
47
54
67
53
55
56
69
75
68
31
29
23
19
14
12
EBITDA*
109,140
279,447
110,221
478,165
357,850
268,492
353,024
432,865
362,501
170,660
358,679
364,734
277,635
212,876
123,082
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Mar 2020
Mar 2019
Mar 2018
Mar 2017
Mar 2016
Mar 2015
Mar 2014
Mar 2013
Mar 2012
Mar 2011
Mar 2010
Tangible Assets
262,034
272,644
316,261
257,049
321,312
365,119
423,625
420,119
259,971
227,674
123,149
112,228
118,105
69,716
56,321
Intangible Assets
150,854
229,559
308,264
402,406
527,425
763,273
1,028,288
1,293,303
1,558,318
964,134
1,150,444
1,336,754
1,523,064
1,230,803
1,300,801
Investments & Other
100
Debtors (Due After 1 year)
Total Fixed Assets
412,888
502,203
624,525
659,455
848,737
1,128,392
1,451,913
1,713,422
1,818,289
1,191,808
1,273,593
1,448,982
1,641,169
1,300,519
1,357,222
Stock & work in progress
205,115
282,611
182,987
252,225
271,847
148,310
189,282
170,771
122,737
97,906
103,660
98,894
81,963
52,977
53,121
Trade Debtors
784,147
645,029
627,074
621,699
674,201
609,420
588,268
551,545
478,202
572,681
568,010
512,525
501,575
305,090
256,714
Group Debtors
Misc Debtors
176,533
198,714
176,075
181,720
164,296
145,770
135,602
122,485
146,083
Cash
447,946
634,576
803,552
861,121
290,536
390,228
306,844
68,928
88,466
56,600
201,871
93,290
12,706
40,893
29,668
misc current assets
total current assets
1,613,741
1,760,930
1,789,688
1,916,765
1,400,880
1,293,728
1,219,996
913,729
835,488
727,187
873,541
704,709
596,244
398,960
339,503
total assets
2,026,629
2,263,133
2,414,213
2,576,220
2,249,617
2,422,120
2,671,909
2,627,151
2,653,777
1,918,995
2,147,134
2,153,691
2,237,413
1,699,479
1,696,725
Bank overdraft
122,064
122,064
1,078,324
244,767
Bank loan
79,705
87,200
93,343
91,451
122,064
Trade Creditors
556,220
567,369
464,936
364,319
412,224
388,475
332,950
394,940
300,719
625,836
623,680
560,889
573,878
385,187
352,620
Group/Directors Accounts
other short term finances
hp & lease commitments
other current liabilities
143,172
174,466
304,481
388,269
86,291
152,320
211,031
368,772
259,640
total current liabilities
779,097
829,035
862,760
844,039
620,579
662,859
666,045
1,842,036
805,126
625,836
623,680
560,889
573,878
385,187
352,620
loans
853,969
926,178
1,007,236
1,102,470
1,163,309
1,248,284
1,307,037
1,078,324
442,223
375,000
375,000
300,000
hp & lease commitments
Accruals and Deferred Income
other liabilities
300,000
300,000
375,000
375,000
375,000
375,000
375,000
375,000
375,000
516,057
753,974
913,553
1,157,394
1,179,874
1,302,134
provisions
49,498
55,883
64,145
35,053
44,282
53,857
67,595
64,145
42,325
33,830
12,660
16,130
19,379
8,641
9,750
total long term liabilities
1,203,467
1,282,061
1,446,381
1,512,523
1,582,591
1,677,141
1,749,632
439,145
1,495,649
992,110
1,141,634
1,304,683
1,476,773
1,188,515
1,311,884
total liabilities
1,982,564
2,111,096
2,309,141
2,356,562
2,203,170
2,340,000
2,415,677
2,281,181
2,300,775
1,617,946
1,765,314
1,865,572
2,050,651
1,573,702
1,664,504
net assets
44,065
152,037
105,072
219,658
46,447
82,120
256,232
345,970
353,002
301,049
381,820
288,119
186,762
125,777
32,221
total shareholders funds
44,065
152,037
105,072
219,658
46,447
82,120
256,232
345,970
353,002
301,049
381,820
288,119
186,762
125,777
32,221
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Mar 2020
Mar 2019
Mar 2018
Mar 2017
Mar 2016
Mar 2015
Mar 2014
Mar 2013
Mar 2012
Mar 2011
Mar 2010
Operating Activities
Operating Profit
-26,867
135,762
-43,389
288,883
44,986
-82,245
-9,186
67,815
121,951
-54,857
145,327
153,724
92,028
129,762
44,674
Depreciation
57,302
64,980
59,468
64,263
77,016
85,722
97,195
80,035
47,682
39,207
27,042
24,700
14,735
13,116
8,410
Amortisation
78,705
78,705
94,142
125,019
235,848
265,015
265,015
285,015
192,868
186,310
186,310
186,310
170,872
69,998
69,998
Tax
-11,016
-40,630
-12,988
-27,989
-31,692
-21,427
-36,383
-12,530
Stock
-77,496
99,624
-69,238
-19,622
123,537
-40,972
18,511
48,034
24,831
-5,754
4,766
16,931
28,986
-144
53,121
Debtors
116,937
40,594
-270
-35,078
83,307
31,320
49,840
49,745
51,604
4,671
55,485
10,950
196,485
48,376
256,714
Creditors
-11,149
102,433
100,617
-47,905
23,749
55,525
-61,990
94,221
-325,117
2,156
62,791
-12,989
188,691
32,567
352,620
Accruals and Deferred Income
-31,294
-130,015
-83,788
301,978
-66,029
-58,711
-157,741
109,132
259,640
Deferred Taxes & Provisions
-6,385
-8,262
29,092
-9,229
-9,575
-13,738
3,450
21,820
8,495
21,170
-3,470
-3,249
10,738
-1,109
9,750
Cash flow from operations
20,871
92,369
225,650
737,079
99,151
261,220
68,392
560,259
216,096
195,069
329,760
288,923
230,166
159,719
163,087
Investing Activities
capital expenditure
-46,692
-21,363
-118,680
-33,209
-27,216
-100,701
-260,183
-867,031
-143,732
-37,963
-18,823
-526,257
-26,511
-1,435,530
Change in Investments
-100
100
cash flow from investments
-46,692
-21,363
-118,680
-33,209
-27,216
-100,701
-260,183
-867,031
-143,732
-37,963
-18,823
-526,257
-26,411
-1,435,630
Financing Activities
Bank loans
-7,495
-6,143
1,892
-30,613
122,064
Group/Directors Accounts
Other Short Term Loans
Long term loans
-72,209
-81,058
-95,234
-60,839
-84,975
-58,753
1,307,037
-1,078,324
636,101
67,223
75,000
300,000
Hire Purchase and Lease Commitments
other long term liabilities
-75,000
-141,057
-237,917
-159,579
-243,841
-22,480
-122,260
1,302,134
share issue
998
2
interest
-81,106
-77,780
-71,196
-75,042
-80,659
-91,867
-80,552
-74,847
-57,010
-25,914
-23,637
-21,673
-9,616
176
74
cash flow from financing
-160,810
-239,981
-164,538
-166,494
-43,570
-150,620
1,226,485
-1,153,171
438,034
-196,608
-183,216
-189,516
267,904
-122,084
1,302,210
cash and cash equivalents
cash
-186,630
-168,976
-57,569
570,585
-99,692
83,384
237,916
-19,538
31,866
-145,271
108,581
80,584
-28,187
11,225
29,668
overdraft
-122,064
-956,260
833,557
244,767
change in cash
-186,630
-168,976
-57,569
570,585
22,372
83,384
1,194,176
-853,095
-212,901
-145,271
108,581
80,584
-28,187
11,225
29,668
guardian pharmacy limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for guardian pharmacy limited. Get real-time insights into guardian pharmacy limited's credit score, group structure and payment trends.
Perform a competitor analysis for guardian pharmacy limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other mid companies, companies in HA1 area or any other competitors across 12 key performance metrics.
guardian pharmacy limited Ownership
GUARDIAN PHARMACY LIMITED group structure
Guardian Pharmacy Limited has no subsidiary companies.
Ultimate parent company
GUARDIAN PHARMACY LIMITED
06324300
GUARDIAN PHARMACY LIMITED Shareholders
The largest shareholders in Guardian Pharmacy Limited include Mr Joe Sivadasam and Ms Seema Hassan.
mr joe sivadasam
25%
ms seema hassan
25%
ms irene oi lin lam
25%
mr andrew ng
25%
guardian pharmacy limited directors
Guardian Pharmacy Limited currently has 2 directors.
The longest serving directors include
Mr Andrew Ng (Jul 2007) and
Mr Joe Sivadasam (Apr 2008).
c/o john cumming ross ltd, kirkland hse 11-15, peterborough rd, harrow, middlesex, HA1 2AX
Bank
-
Legal Advisor
-
guardian pharmacy limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 10 charges/mortgages relating to guardian pharmacy limited. Currently there are 3 open charges and 7 have been satisfied in the past.
guardian pharmacy limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for GUARDIAN PHARMACY LIMITED. This can take several minutes, an email will notify you when this has completed.
guardian pharmacy limitedCompanies House Filings - See Documents
